Top Industrial Enzymes Companies

The industrial enzymes market is estimated at USD 8.42 billion in 2025 and is projected to reach USD 12.01 billion by 2030, at a CAGR of 7.3% from 2025 to 2030. The market for industrial enzymes is growing as industries require cleaner, safer, and more efficient processing methods. Manufacturers switch to enzymes to cut emissions, energy consumption, and waste as environmental regulations become stricter. Enzymes improve shelf life and quality in food and beverage products. Moreover, in agriculture and biofuels, industrial enzymes facilitate renewable production and enhance nutrient utilization. Improvements in protein engineering, AI-powered enzyme design, and fermentation technology have enhanced enzyme cost and stability benefits, further fueling adoption. Growing health consciousness, automation in industries, and worldwide interest in green practices are spurring the momentum of the market in developed and emerging economies alike.

Top 10 Companies in the Industrial Enzymes Market

• BASF SE (Germany)
• International Flavors & Fragrances Inc. (US)
• dsm-firmenich (Switzerland)
• Associated British Foods plc (England)
• Novozymes A/S (Denmark)
• Kerry Group plc. (Ireland)
• Dyadic International Inc (US)
• Advanced Enzyme Technologies (India)
• Aumgene Biosciences (India)
• Amano Enzyme Inc (Japan)

To know about the assumptions considered for the study download the pdf brochure

Some of the major players in the industrial enzymes market with significant global presence include BASF SE (Germany), International Flavors & Fragrances Inc. (US), DSM-Firmenich (Switzerland), Associated British Foods plc (England), Novozymes A/S (Denmark), Kerry Group plc. (Ireland), and Dyadic International Inc (US). These players have incorporated various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions to strengthen their international footprint and capture a greater share of the industrial enzymes market. These organic and inorganic strategies have allowed the market players to expand across geographies by offering the enzymes. For example, companies play a pivotal role in this market's expansion through continuous research, development, and strategic initiatives. A notable example is Novozymes, formed from the merger of Novozymes and Chr. Hansen. In May 2024, Novonesis introduced "Cell-Tech," a biosolution utilizing nitrogen-fixing bacteria to increase soybean yields in Southern and Eastern Africa. Additionally, the company partnered with Carbios to produce PET-degrading enzymes, aiming to address plastic waste challenges. These initiatives underscore the industry's commitment to sustainability and innovation.

International Flavors and Fragrances Inc. (US)

International Flavors & Fragrances Inc. (IFF) is a major player in the global industrial enzymes market, particularly after its 2021 merger with DuPont’s Nutrition & Biosciences unit, which significantly expanded its enzyme capabilities across food, health, and industrial applications. Through its Health & Biosciences division, IFF develops innovative enzyme solutions for baking, dairy, brewing, animal nutrition, and sustainable biofuels. The company focuses on clean-label and precision enzyme formulations that meet rising consumer demand for natural and functional ingredients. In 2025, IFF launched an enzyme blend targeting microbiome-supportive foods, designed to enhance digestive health by improving prebiotic release from plant-based matrices. This reflects IFF’s growing investment in functional nutrition and gut health innovation, aligning with global wellness trends. With a strong biotech platform, extensive fermentation expertise, and global reach, IFF remains a key driver of industrial enzyme innovation across both mature and emerging markets.

Associated British Foods plc (England)

Associated British Foods plc (ABF), through its subsidiary AB Enzymes, plays a strategic role in the global enzyme market, focusing on industrial applications in food, animal feed, and textiles. AB Enzymes is recognized for its tailored enzyme solutions that enhance baking performance, grain processing, and plant-based product quality. The company is particularly strong in offering clean-label and non-GMO enzyme alternatives, meeting regulatory and consumer expectations across Europe, North America, and Asia. In late 2023, AB Enzymes launched VERON® GMS+, a next-generation baking enzyme designed to replace traditional emulsifiers like monoglycerides. This product supports manufacturers in meeting clean-label demands while maintaining dough stability and texture. ABF’s vertical integration, global distribution network, and focus on sustainability position it as a reliable enzyme supplier in highly regulated markets. By continuously investing in R&D and expanding environmentally friendly enzyme technologies, ABF is reinforcing its competitiveness and commitment to innovation in the growing specialty enzyme segment.

Kerry Group plc (Ireland)

Kerry Group plc, headquartered in Tralee, Ireland, is a global leader in taste and nutrition solutions, serving the food, beverage, and other industries. With a workforce exceeding 23,000 employees, the company operates in over 140 countries, offering a broad portfolio of functional and nutritional ingredients. Kerry's enzyme business focuses on delivering sustainable and efficient solutions across various applications, including dairy, bakery, brewing, and biopharma. The company's enzyme offerings are designed to enhance product quality, shelf life, and nutritional value while optimizing manufacturing processes.

In December 2023, Kerry announced the acquisition of the global lactase enzyme business from Chr. Hansen and Novozymes for USD 170 million. This acquisition, expected to close in the first half of 2024, includes NOLA® products and aims to strengthen Kerry's biotechnology capabilities, particularly in producing lactose-free and reduced-sugar dairy products. Further expanding its enzyme portfolio, in November 2024, Kerry acquired LactoSens® biosensor technology from Austria-based DirectSens. LactoSens® offers rapid and accurate lactose detection, enabling food manufacturers to meet stringent regulatory requirements and improve process efficiency. These strategic acquisitions underscore Kerry's commitment to advancing enzyme technology and providing innovative solutions to meet evolving consumer demands.

Market Ranking

The global industrial enzymes market is becoming consolidated, with the largest five players—controlled by Novozymes, DSM-Firmenich, and IFF—accounting for more than 50% of the overall market share. These players draw strength from large R&D pipelines, strategic merger and acquisition activities, and favorable industry integration in sectors like food processing, pharmaceuticals, and industrial biotechnology. For example, Novozymes' acquisition of Chr. Hansen (completed in 2024) further strengthened its dominance by increasing its strength in microbial and fermentation-based technologies. Mid-range players, such as BASF, Kerry Group, and Advanced Enzyme Technologies, have concentrated leadership in select application segments or geography. Their market positions are normally between 1% and 7%, frequently founded on product specialization—i.e., digestive enzymes, baking improvers, or clean-label offerings. The existence of a 36% market share with small firms and startups indicates a rich innovation space and a fragmented tail. Startups are fast-evolving in enzyme personalization, synthetic biology, and AI-assisted enzyme design. This tail-end competition, whilst individually insignificant, overall impacts pricing, innovation cycles, and regional dynamics, particularly in Asia Pacific and Latin America, where food, feed, and diagnostic enzyme demand is rapidly increasing.

Related Reports:

Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, and Nucleases), Application (Food & Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil, and Oil Treatment), Source, Formulation, and Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com